The earnings call presented a mixed outlook with significant progress in installations and partnerships, particularly in the U.S. and Europe, and improvements in teleradiology revenue. However, these positive developments were offset by increased losses and stagnant revenue in AI solutions, indicating financial challenges.

Company Guidance

During the Nanox Imaging Second Quarter 2025 earnings call, the company provided guidance on its key initiatives and performance metrics. Nanox has set a clear target of installing or deploying 100 Nanox.ARC systems by the end of 2025, with over 20 systems already operational and scanning patients. Revenue for the reported period was $3.0 million, with a gross loss of $3.2 million on a GAAP basis. The company highlighted a focus on expanding its commercial footprint, particularly in the U.S. market, while also making inroads in European countries such as Romania and Greece following the CE mark designation. Non-GAAP net loss for the quarter was $10.9 million, a $2.5 million increase from the comparable period. The company is aiming for revenue growth in the second half of 2025, supported by a robust clinical program and partnerships with leading academic institutions, including a collaboration with Duke University Medical Center. Nanox is also advancing its AI solutions, with revenue from AI solutions reported at $0.1 million for the quarter. Additionally, the company has entered into a multiyear Volume Supply Agreement with Fabrinet to support scalable production of the Nanox.ARC X, aiming to enhance manufacturing efficiency and reduce costs over time.

Expansion of Nanox.ARC Installations

Nanox is on track to meet their goal of 100 Nanox.ARC systems installations by the end of 2025, with over 20 systems currently operating and scanning patients.

Partnerships and Collaborations

Several collaborations announced, including with Duke University, Keiser University, and Ezra, enhancing clinical strategies and expanding AI capabilities.

Revenue Growth in Teleradiology Services

Revenue from teleradiology services increased to $2.7 million with a gross profit margin improvement from 15% to 18% compared to the previous year.

Nano-X Imaging (NNOX) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

NNOX Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 18, 2025	2025 (Q3)	-0.20 / -	-0.23	―	―	―
Aug 12, 2025	2025 (Q2)	-0.19 / -0.23	-0.23	0.00% (0.00)	―
May 22, 2025	2025 (Q1)	- / -	-0.21	―	―
Mar 31, 2025	2024 (Q4)	-0.19 / -0.21	-0.21	0.00% (0.00)	―
Nov 21, 2024	2024 (Q3)	-0.22 / -0.23	-0.37	37.84% (+0.14)	―
Aug 20, 2024	2024 (Q2)	-0.22 / -0.23	-0.31	25.81% (+0.08)	―
May 28, 2024	2024 (Q1)	- / -	-0.21	―	―
Apr 01, 2024	2023 (Q4)	-0.26 / -0.21	-0.21	0.00% (0.00)	―
Nov 28, 2023	2023 (Q3)	-0.30 / -0.37	-0.37	0.00% (0.00)	―
Aug 17, 2023	2023 (Q2)	-0.27 / -0.31	-0.38	18.42% (+0.07)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

NNOX Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 12, 2025	$4.71	$4.46	-5.31%
May 22, 2025	$5.24	$5.24	0.00%
Mar 31, 2025	$5.23	$5.00	-4.40%
Nov 21, 2024	$5.89	$6.16	+4.58%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.